Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
|
|
33.
|
|
|
34.
|
Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma. [electronic resource] by
- Campbell, P
- Walker, P
- Avery, S
- Patil, S
- Curtis, D
- Schwarer, A
- Wei, A
- Kalff, A
- Muirhead, J
- Spencer, A
Producer: 20150407
In:
Blood cancer journal vol. 4
Availability: No items available.
|
|
35.
|
Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-up. [electronic resource] by
- Patil, S
- Spencer, A
- Schwarer, A
- Lewis, I
- Hertzberg, M
- Avery, S
- Wei, A
- Noutsos, T
- Paul, E
- Taouk, Y
- Muirhead, J
Producer: 20101012
In:
Bone marrow transplantation vol. 45
Availability: No items available.
|
|
36.
|
|
|
37.
|
Adverse impact of high donor CD3+ cell dose on outcome following tandem auto-NMA allogeneic transplantation for high-risk myeloma. [electronic resource] by
- Nair, A P
- Walker, P
- Kalff, A
- Bergin, K
- Hocking, J
- Avery, S
- Curtis, D J
- Patil, S
- Das, T
- Klarica, D
- Morgan, S
- Muirhead, J
- Gorniak, M
- Reynolds, J
- Spencer, A
Producer: 20180307
In:
Bone marrow transplantation vol. 52
Availability: No items available.
|